# FDA 483 - PPD Development, L.P. - April 05, 2023

Source: https://www.keypedia.com/records/483/ppd-development-lp/199ff82e-a934-4fac-9fec-faa0405a7238

> FDA 483 for PPD Development, L.P. on April 05, 2023. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: PPD Development, L.P.
- Inspection Date: 2023-04-05
- Product Type: biologics
- Office Name: Minneapolis District Office
- Summary: An FDA inspection of PPD Development, L.P., a drug/device/biologics contract testing lab in Middleton, WI, revealed a significant deficiency in their quality system. The firm's procedures for corrective and preventive actions (CAPA) were found to be inadequate. Specifically, their CAPA SOP did not require effectiveness checks for all corrective and preventive actions, as demonstrated by a CAPA related to failed container closure integrity testing.

## Related Documents

- [483 - Unknown Date](https://www.keypedia.com/records/483/ppd-development-lp/61346431-fa4f-4c39-9544-0c075a540d6b)
- [483 - 2026-05-14](https://www.keypedia.com/records/483/ppd-development-lp/378f5be0-1030-40fb-b0fd-ea96e1302769)
- [EIR - 2021-07-16](https://www.keypedia.com/records/eir/ppd-development-lp/f8eac3b9-7684-413c-8dba-fe6d849d482a)
- [483 - 2021-07-12](https://www.keypedia.com/records/483/ppd-development-lp/ccfcb620-b78a-4d74-bd5f-0ac42cce65eb)
- [483 - 2025-09-25](https://www.keypedia.com/records/483/ppd-development-lp/e2239a11-ea51-47a5-b646-89e4ea475acb)

## Related Officers

- [Nicholas Z. Lu](https://www.keypedia.com/people/nicholas-z-lu/17448aca-e316-424c-b7b2-88c8baffc359)
- [Anders Evenson](https://www.keypedia.com/people/anders-evenson/a37224ef-88c8-47ed-83ba-421695dd2228)

Company: https://www.keypedia.com/companies/ppd-development-lp/0d495b78-4879-42fc-8887-4e0294e69720

Office: https://www.keypedia.com/offices/minneapolis-district-office/c79fc8dc-f884-48fc-ba80-2947f662511d